Bring your questions about the newest weight loss drug for the stars, semaglutide (branded Ozempic for type 2 diabetes treatment and Wegovy for weight management).
Featuring:
- Jeremy Faust, MD, editor-in-chief of MedPage Today (@jeremysamuelfaust)
- Karl Nadolsky, DO, assistant clinical professor of medicine, MSU College of Human Medicine (@drkarlnadolsky)
- Fatima Cody Stanford, MD, MPH, MPA, MBA, associate professor of medicine and pediatrics, Harvard Medical School (@askdrfatima)
How do I join? Follow @MedPage on Instagram!
When is the event? Tune in Monday, November 14, at 12 p.m. ET.
Can I submit questions? Yes, we encourage questions! Submit your questions prior to the event by commenting below.
Related articles:
A Deeper Look at Hollywood’s Newest Weight Loss Drug
Demand Rising for ‘Bootlegged’ Weight-Loss Drug
Weight-Loss Drug Wegovy Exceeded Expectations, and Supply
FDA OKs Injectable Semaglutide for Chronic Weight Management
‘Mind Blowing’ Results in Teen Weight-Loss Trial
-
![author['full_name']](data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs=)
Gillian Booth is a Social Media Manager for MedPage Today. She is based in Philadelphia. Interested in collaborating with @MedPageToday on social media? Email: gbooth@everydayhealthgroup.com Follow
![author['full_name']](https://clf1.medpagetoday.com/media/images/author/GBooth_188.jpg)
